These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19053772)

  • 1. Bisphosphonate inhibition of a Plasmodium farnesyl diphosphate synthase and a general method for predicting cell-based activity from enzyme data.
    Mukkamala D; No JH; Cass LM; Chang TK; Oldfield E
    J Med Chem; 2008 Dec; 51(24):7827-33. PubMed ID: 19053772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of bone resorption and Dictyostelium discoideum growth inhibition by bisphosphonate drugs.
    Szabo CM; Martin MB; Oldfield E
    J Med Chem; 2002 Jul; 45(14):2894-903. PubMed ID: 12086477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of a series of aromatic bisphosphonates.
    Barney RJ; Wasko BM; Dudakovic A; Hohl RJ; Wiemer DF
    Bioorg Med Chem; 2010 Oct; 18(20):7212-20. PubMed ID: 20832326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches for Designing new Potent Inhibitors of Farnesyl Pyrophosphate Synthase.
    Rodriguez JB; Falcone BN; Szajnman SH
    Expert Opin Drug Discov; 2016; 11(3):307-20. PubMed ID: 26781029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The farnesyl-diphosphate/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates.
    Ling Y; Li ZH; Miranda K; Oldfield E; Moreno SN
    J Biol Chem; 2007 Oct; 282(42):30804-16. PubMed ID: 17724033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights about the structure of farnesyl diphosphate synthase (FPPS) and the activity of bisphosphonates on the proliferation and ultrastructure of Leishmania and Giardia.
    Gadelha APR; Brigagao CM; da Silva MB; Rodrigues ABM; Guimarães ACR; Paiva F; de Souza W; Henriques C
    Parasit Vectors; 2020 Apr; 13(1):168. PubMed ID: 32248823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-bisphosphonate inhibitors of isoprenoid biosynthesis identified via computer-aided drug design.
    Durrant JD; Cao R; Gorfe AA; Zhu W; Li J; Sankovsky A; Oldfield E; McCammon JA
    Chem Biol Drug Des; 2011 Sep; 78(3):323-32. PubMed ID: 21696546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
    Dunford JE; Thompson K; Coxon FP; Luckman SP; Hahn FM; Poulter CD; Ebetino FH; Rogers MJ
    J Pharmacol Exp Ther; 2001 Feb; 296(2):235-42. PubMed ID: 11160603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of a potent phenylalkyl bisphosphonate inhibitor bound to farnesyl and geranylgeranyl diphosphate synthases.
    Cao R; Chen CK; Guo RT; Wang AH; Oldfield E
    Proteins; 2008 Nov; 73(2):431-9. PubMed ID: 18442135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural characterization of substrate and inhibitor binding to farnesyl pyrophosphate synthase from Pseudomonas aeruginosa.
    Schmidberger JW; Schnell R; Schneider G
    Acta Crystallogr D Biol Crystallogr; 2015 Mar; 71(Pt 3):721-31. PubMed ID: 25760619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase.
    Wiemer AJ; Tong H; Swanson KM; Hohl RJ
    Biochem Biophys Res Commun; 2007 Feb; 353(4):921-5. PubMed ID: 17208200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thienopyrimidine bisphosphonate (ThPBP) inhibitors of the human farnesyl pyrophosphate synthase: optimization and characterization of the mode of inhibition.
    Leung CY; Park J; De Schutter JW; Sebag M; Berghuis AM; Tsantrizos YS
    J Med Chem; 2013 Oct; 56(20):7939-50. PubMed ID: 23998921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of potent bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase via targeted interactions with the active site 'capping' phenyls.
    De Schutter JW; Shaw J; Lin YS; Tsantrizos YS
    Bioorg Med Chem; 2012 Sep; 20(18):5583-91. PubMed ID: 22884353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.
    Leon A; Liu L; Yang Y; Hudock MP; Hall P; Yin F; Studer D; Puan KJ; Morita CT; Oldfield E
    J Med Chem; 2006 Dec; 49(25):7331-41. PubMed ID: 17149863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human farnesyl pyrophosphate synthase inhibition by nitrogen bisphosphonates: a 3D-QSAR study.
    Fernández D; Ortega-Castro J; Frau J
    J Comput Aided Mol Des; 2013 Aug; 27(8):739-54. PubMed ID: 23979193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic insights into protonation state as a critical factor in hFPPS enzyme inhibition.
    Fernández D; Ortega-Castro J; Mariño L; Perelló J; Frau J
    J Comput Aided Mol Des; 2015 Jul; 29(7):667-80. PubMed ID: 26081258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a bisphosphonate that inhibits isopentenyl diphosphate isomerase and farnesyl diphosphate synthase.
    Thompson K; Dunford JE; Ebetino FH; Rogers MJ
    Biochem Biophys Res Commun; 2002 Jan; 290(2):869-73. PubMed ID: 11785983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical evidence for nitrogen-containing bisphosphonate inhibition of farnesyl diphosphate (FPP) synthase in the kidney: implications for renal safety.
    Lühe A; Künkele KP; Haiker M; Schad K; Zihlmann C; Bauss F; Suter L; Pfister T
    Toxicol In Vitro; 2008 Jun; 22(4):899-909. PubMed ID: 18325729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro and In Vivo Investigation of the Inhibition of Trypanosoma brucei Cell Growth by Lipophilic Bisphosphonates.
    Yang G; Zhu W; Kim K; Byun SY; Choi G; Wang K; Cha JS; Cho HS; Oldfield E; No JH
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7530-9. PubMed ID: 26392508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Inhibition of the Bifunctional Farnesyl/Geranylgeranyl Diphosphate Synthase in Malaria Parasites via a New Small-Molecule Binding Site.
    Gisselberg JE; Herrera Z; Orchard LM; Llinás M; Yeh E
    Cell Chem Biol; 2018 Feb; 25(2):185-193.e5. PubMed ID: 29276048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.